help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johansson, B. L.
Right arrow Articles by Wahren, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johansson, B. L.
Right arrow Articles by Wahren, J.

Journal of Clinical Endocrinology & Metabolism, Vol 77, 976-981, Copyright © 1993 by Endocrine Society

ARTICLES

Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1

BL Johansson, A Kernell, S Sjoberg and J Wahren
Department of Clinical Physiology, Karolinska Hospital, Stockholm, Sweden.

The possible influence of C-peptide on renal function and metabolic control in patients with type 1 diabetes was examined in a double blind, randomized study. Nine patients received insulin and equimolar amounts of biosynthetic human C-peptide for 1 month (group 1), and nine were given insulin only (group 2). C-Peptide levels in plasma ranged from 0.3-2.6 nmol/L in group 1 during the study, whereas group 2 had undetectable levels. The urinary excretion of albumin in group 1 was 21 +/- 6 micrograms/min before the study and decreased by 40% and 55% after 2 and 4 weeks, respectively (P < 0.05). No change was seen in group 2. The glomerular filtration rate fell by 6% after 2 and 4 weeks (P < 0.05) in group 1, whereas no change was observed in group 2. Fluorescein leakage across the blood-retinal barrier decreased by 30% in group 1 (P < 0.05) and was unaltered in group 2. Hemoglobin-A1c and fructosamine values decreased by 9-16% in group 1 (P < 0.05), but not in group 2. The findings suggest that administration of C-peptide plus insulin, compared to insulin alone, to type 1 diabetic patients may reduce glomerular permeability and improve metabolic control.


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
B. Samnegard, S. H. Jacobson, B.-L. Johansson, K. Ekberg, B. Isaksson, J. Wahren, and M. Sjoquist
C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats
Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1385 - 1391.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
Z. T. Bloomgarden
Diabetes Complications
Diabetes Care, June 1, 2004; 27(6): 1506 - 1514.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
B.-L. Johansson, J. Wahren, and J. Pernow
C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism
Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E864 - E870.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. Ekberg, T. Brismar, B.-L. Johansson, B. Jonsson, P. Lindstrom, and J. Wahren
Amelioration of Sensory Nerve Dysfunction by C-Peptide in Patients With Type 1 Diabetes
Diabetes, February 1, 2003; 52(2): 536 - 541.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Hansen, B.-L. Johansson, J. Wahren, and H. von Bibra
C-Peptide Exerts Beneficial Effects on Myocardial Blood Flow and Function in Patients With Type 1 Diabetes
Diabetes, October 1, 2002; 51(10): 3077 - 3082.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
L. Luzi, G. Perseghin, M. D. Brendel, I. Terruzzi, A. Battezzati, M. Eckhard, D. Brandhorst, H. Brandhorst, S. Friemann, C. Socci, et al.
Metabolic Effects of Restoring Partial {beta}-Cell Function After Islet Allotransplantation in Type 1 Diabetic Patients
Diabetes, February 1, 2001; 50(2): 277 - 282.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. Wahren, K. Ekberg, J. Johansson, M. Henriksson, A. Pramanik, B.-L. Johansson, R. Rigler, and H. Jornvall
Role of C-peptide in human physiology
Am J Physiol Endocrinol Metab, May 1, 2000; 278(5): E759 - E768.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. Rigler, A. Pramanik, P. Jonasson, G. Kratz, O. T. Jansson, P.-A. Nygren, S. Stahl, K. Ekberg, B.-L. Johansson, S. Uhlen, et al.
Specific binding of proinsulin C-peptide to human cell membranes
PNAS, November 9, 1999; 96(23): 13318 - 13323.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. E. Jensen and E. J. Messina
C-peptide induces a concentration-dependent dilation of skeletal muscle arterioles only in presence of insulin
Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1223 - H1228.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
L. Luzi
Pancreas Transplantation and Diabetic Complications
N. Engl. J. Med., July 9, 1998; 339(2): 115 - 117.
[Full Text]

Home page
 ScienceHome page
Y. Ido, A. Vindigni, K. Chang, L. Stramm, R. Chance, W. F. Heath, R. D. DiMarchi, E. Di Cera, and J. R. Williamson
Prevention of Vascular and Neural Dysfunction in Diabetic Rats by C-Peptide
Science, July 25, 1997; 277(5325): 563 - 566.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society